Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 253

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 19
Chunk 253
---
 agreement with SciSparc for the lease of office space in Tel Aviv, Israel, having a total
area of approximately 240 120 23,300 6,500 10

On
March 31, 2024, the Company and SciSparc agreed to terminate the lease agreement prior to the initial term of the lease. As a result,
the Company paid early termination fees of approximately $ 13,000 3,000

On
June 13, 2024, the Company entered into an agreement with SciSparc for the lease of office space in Tel Aviv, Israel, having a total
area of approximately 386 193 12,500 3,400 10

                                   ROU                         
  Balance, October 31, 2023        $                        -  
  Addition                                            181,779  
  Early termination of office                        ( 88,562  
  Accumulated depreciation                           ( 39,023  
  Exchange                                            ( 2,531  
  Balance, October 31, 2024        $                   51,663  

                                   Lease                    
  Balance, October 31, 2023        $                     -  
  Addition                                         181,779  
  Early termination of office                     ( 88,905  
  Lease payments                                  ( 42,587  
  Interest expense                                   5,386  
  Exchange                                         ( 2,531  
  Balance, October 31, 2024        $                53,142  

Amounts
recognized in profit or loss

                    Year ended               
                    October 31,              
 ─────────────────────────────────────────────
                    2024                     
  Depreciation      $                39,023  
  Interest                            5,386  
                    $                44,409  

F-19

CLEARMIND
MEDICINE INC.

Notes to
the Consolidated Financial Statements

(Expressed
in United States Dollars)

  Short-term   

  Polyrizon Ltd. – shares and      $                     -      $              350,400             -      ( 61,012      289,388  
  warrants (1)                                                                                                                   
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                   October 31,                  Additions                                                        
  Xylo Technologies Ltd.                            86,112                     -            ( 78,500       ( 7,612      -        
                                   $                86,